Introduction to Cartalax 20mg
Cartalax is a synthetic peptide intended solely for research purposes to investigate its potential effects on cartilage repair and joint health. The 20mg dosage is standardized to ensure consistency and reliability in experimental studies.
Key Research Areas
Research involving Cartalax 20mg includes:
Promoting cartilage repair in preclinical models
Enhancing joint function in laboratory settings
Investigating anti-inflammatory effects related to joint health
Important Notice:
Cartalax 20mg is for research use only. It is not approved for human or veterinary use, consumption, or administration. This product is not intended for sale or distribution as a therapeutic or diagnostic agent.
| Property | Description |
| Chemical Sequence | Lys-Glu |
| CAS | 32603-68-2 |
| Molecular Formula | C11H22N4O5 |
| Molecular Weight | Approximately 290.32 g/mol |
| Appearance | White Lyophilized Powder |
Research Use Only:
Cartalax 20mg is intended strictly for in vitro testing and laboratory experimentation. It is not intended for human or animal medical use. It is not a drug, food, or cosmetic and should not be misbranded, misused, or mislabeled as such.
